Advertisement

Review Series - June 14, 2018

Emerging Immunotherapies for Hematologic Diseases

Edited with an introduction by Blood Associate Editor Catherine M. Bollard, and Blood authors Sophie Paczesny and Steven Z. Pavletic,  we present a review series on emerging immunotherapies for hematologic disease, discussing chimeric antigen receptor T cells and their toxicities, vaccine therapies, and cellular therapies for graft-versus-host disease.

Catherine M. Bollard, MBChB, MD, and Leslie S. Kean, MD, PhD, share highlights of this review series.

 


Review Series Articles:

Introduction to a review series on emerging immunotherapies for hematologic diseases
Sophie Paczesny, Steven Z. Pavletic and Catherine M. Bollard